US 11,779,697 B2
Device for subcutaneous delivery of fluid medicament
Eran Shor, Tel Aviv (IL); Tsabar Mor, Adi (IL); Tamir Ben David, Arugot (IL); Nir Lilach, Kfar Yehoshua (IL); Rami Grossfeld, Haifa (IL); Shai Alfandari, Ramat Hashofet (IL); Ram Nadler, Haifa (IL); Dmitry Golom, Haifa (IL); Daniel Shaki, Herzliya (IL); Yoav Tikochinsky, Tel Aviv (IL); and Serdar Ozsumer, Milan (IT)
Assigned to NeuroDerm, Ltd., Rehovot (IL)
Filed by NeuroDerm, Ltd., Rehovot (IL)
Filed on Feb. 17, 2023, as Appl. No. 18/111,383.
Application 18/111,383 is a continuation of application No. 18/065,373, filed on Dec. 13, 2022.
Application 18/065,373 is a continuation in part of application No. 16/685,364, filed on Nov. 15, 2019, granted, now 11,554,210, issued on Jan. 17, 2023.
Application 16/685,364 is a continuation of application No. 16/351,061, filed on Mar. 12, 2019, granted, now 10,603,430, issued on Mar. 31, 2020.
Application 16/351,061 is a continuation of application No. 16/027,804, filed on Jul. 5, 2018, abandoned.
Claims priority of provisional application 62/576,362, filed on Oct. 24, 2017.
Claims priority of provisional application 62/529,784, filed on Jul. 7, 2017.
Prior Publication US 2023/0201453 A1, Jun. 29, 2023
Int. Cl. A61M 5/142 (2006.01); A61J 1/20 (2006.01); H03H 9/05 (2006.01); H03H 9/54 (2006.01); A61M 5/145 (2006.01); A61M 5/172 (2006.01); A61M 5/14 (2006.01); A61M 5/315 (2006.01); A61M 5/34 (2006.01); H03H 9/64 (2006.01); A61M 5/178 (2006.01); A61M 5/31 (2006.01); A61M 5/158 (2006.01)
CPC A61M 5/14248 (2013.01) [A61J 1/2003 (2015.05); A61J 1/2013 (2015.05); A61M 5/1407 (2013.01); A61M 5/1413 (2013.01); A61M 5/1456 (2013.01); A61M 5/14216 (2013.01); A61M 5/1723 (2013.01); A61M 5/1782 (2013.01); A61M 5/31528 (2013.01); A61M 5/345 (2013.01); H03H 9/0509 (2013.01); H03H 9/0585 (2013.01); H03H 9/54 (2013.01); H03H 9/64 (2013.01); A61M 2005/14252 (2013.01); A61M 2005/14268 (2013.01); A61M 2005/14506 (2013.01); A61M 2005/14573 (2013.01); A61M 2005/1586 (2013.01); A61M 2005/1726 (2013.01); A61M 2005/3125 (2013.01); A61M 2202/0468 (2013.01); A61M 2205/13 (2013.01); A61M 2205/33 (2013.01); A61M 2205/50 (2013.01); A61M 2205/8206 (2013.01); A61M 2210/04 (2013.01)] 5 Claims
OG exemplary drawing
 
1. A method for treating Parkinson's disease in a patient in need thereof, comprising:
subcutaneously administering to the patient a liquid medicament comprising: levodopa and carbidopa, wherein subcutaneously administering comprises:
providing a device comprising:
a reusable part comprising:
a drive component; and
a control unit for controlling the drive component; and
a disposable part engageable with the reusable part, the disposable part comprising:
a reservoir that contains the liquid medicament, wherein the reservoir comprises a bushing, the bushing fixedly mounted in the reservoir;
a plunger head moveable by a lead screw in the reservoir;
and
a nut concentrically secured by and rotatable in the bushing, the nut threadedly engaged with a thread of the lead screw
engaging the reusable part with the disposable part thereby detachably coupling the nut with the drive component;
fluidically coupling the reservoir to the subcutaneous tissue of the patient;
rotating the nut in the bushing to linearly displace the lead screw; and thereby
administering the liquid medicament from the reservoir to the subcutaneous tissue of the patient.